Adrenal infarction with latent myelodysplastic/myeloproliferative neoplasm, unclassifiable with JAK2V617F mutation

Abstract

Hematopoietic neoplasms are considered a differential diagnosis when encountering adrenal infarction. We should recognize thatJAK2 V617F mutation can cause thrombogenicity even if there are no abnormal findings in the blood cell counts.